Lorazepam Price Trend and Forecast 2026-2027

The US paid the most for lorazepam in Q2 2026: USD 304/KG, up 2.0% from USD 298 in Q1. The steady formulation and hospital demand kept things firm there. Worldwide, the average moved up 2.1%, to USD 246/KG from USD 241, largely because the chlorobenzophenone feedstock costs kept climbing across every region we track. What about H2 2026? We'd expect a global average somewhere in the USD 243-264/KG range, with the steady pharmaceutical-formulation demand doing most of the work.

Lorazepam is synthesized from a chlorobenzophenone intermediate through a multi-step process that builds the benzodiazepine core structure, producing an active pharmaceutical ingredient used in anxiety, seizure, and sedation treatment across both hospital and outpatient settings. As a long-established, off-patent generic, its demand tracks routine prescribing volumes and hospital procurement more than any single innovation cycle. Three things move the price more than anything else: the chlorobenzophenone feedstock costs, the pharmaceutical-formulation demand tied to prescribing volumes, and how much specialized API production capacity the producers are running.

The controlled-substance regulatory framework this API operates under deserves some explanation, since it shapes the market in ways that don't apply to most other generic pharmaceuticals in this pipeline. Benzodiazepines like lorazepam are subject to controlled-substance manufacturing and distribution regulations in most major markets, which limits the number of facilities licensed to produce them and adds compliance costs that a non-controlled generic API wouldn't face. That regulatory structure has kept production more concentrated among established, licensed manufacturers than a comparably sized conventional generic market would typically show. Buyers new to this market sometimes underestimate how much that structural detail matters until they see it play out in the pricing data over a full cycle, which is exactly why we've made a point of covering it here in detail.

The hospital-demand segment deserves a mention too, since it represents a genuinely important and fairly steady portion of overall consumption. Lorazepam's use in acute anxiety management, seizure control, and pre-procedure sedation makes it a routine stock item across hospital pharmacies, a demand base that's stayed dependable given how essential these applications are to standard clinical care regardless of broader economic conditions. That distinction is worth keeping in mind for anyone comparing this market to more conventional pharmaceutical intermediates.

Lorazepam Price Forecast for 2026

Supply and demand should stay moderately tight through H2 2026, with the chlorobenzophenone feedstock costs doing most of the work on pricing. Germany and the US both kept the formulation and hospital demand steady through H1, and that's likely to continue. India's formulation sector kept the demand building, while China's large API base kept it the most affordable of the four. None of the four markets we track is showing signs of genuine disruption heading into the back half of the year. None of the four markets we track is showing signs of genuine disruption heading into the back half of the year.

Buyers should keep an eye on the controlled-substance licensing landscape specifically, since the limited number of qualified manufacturers means any disruption at a major facility tends to have an outsized effect on pricing relative to a less regulated generic drug market. That's worth building into any longer-range planning rather than assuming current conditions will simply persist unchanged.

The hospital-demand segment tends to hold up more steadily than broader outpatient prescribing trends, given how essential acute anxiety and seizure-management applications are to routine clinical care.

What could push prices higher? A chlorobenzophenone feedstock spike, or a stronger-than-expected hospital-demand surge across the major healthcare systems. What could pull them lower? Expanded low-cost Chinese or Indian API capacity outpacing the demand.

For the Quarter Ending June 2026

Lorazepam Prices Q2 2026:

• China: USD 199/KG
• India: USD 221/KG
• United States: USD 304/KG
• Germany: USD 284/KG

Lorazepam Prices in China

China's lorazepam producers passed through the firmer feedstock costs this quarter, and the domestic formulation demand held steady. The gain came to 2.1%, USD 195/KG to USD 199. That kept China comfortably the most affordable of the four markets.

Why did the price of Lorazepam change in Q2 2026 in China?

The chlorobenzophenone feedstock costs firmed through the quarter, and the domestic formulation demand held its ground right alongside that.

Lorazepam Prices in India

India climbed 1.8% to USD 221/KG, the formulation demand continuing to build through the period.

Why did the price of Lorazepam change in Q2 2026 in India?

The formulation demand kept building, and that alone explains most of the move here.

Lorazepam Prices in United States

USD 304/KG. That's where the US landed in Q2, up 2.0% from USD 298 in Q1. The hospital demand stayed steady, and the feedstock costs climbed just enough to push things higher.

Why did the price of Lorazepam change in Q2 2026 in United States?

The hospital demand didn't move much, honestly. It was the chlorobenzophenone feedstock costs doing most of the work this quarter.

Lorazepam Prices in Germany

Germany gained 2.2% to USD 284/KG, the established formulation demand staying firm through the period.

Why did the price of Lorazepam change in Q2 2026 in Germany?

Germany's premium held for the usual reason: steady formulation demand backed by firming feedstock costs.

For the Quarter Ending March 2026

Lorazepam Prices Q1 2026:

• China: USD 195/KG
• India: USD 217/KG
• United States: USD 298/KG
• Germany: USD 278/KG

Lorazepam Prices in China

China gained 2.1% to USD 195/KG, the demand firming as the year opened.

Why did the price of Lorazepam change in Q1 2026 in China?

The domestic formulation demand firmed as the year opened, and the chlorobenzophenone feedstock costs edged higher right alongside it.

Lorazepam Prices in India

Indian lorazepam rose 1.9% to USD 217/KG, the formulation demand firming with the new year.

Why did the price of Lorazepam change in Q1 2026 in India?

The formulation demand firmed with the new year, and the feedstock costs kept climbing steadily too.

Lorazepam Prices in United States

US lorazepam climbed 2.1% to USD 298/KG, the hospital demand staying firm through the quarter.

Why did the price of Lorazepam change in Q1 2026 in United States?

The hospital demand stayed firm, and the feedstock costs firmed alongside it.

Lorazepam Prices in Germany

German lorazepam rose 2.2% to USD 278/KG, the formulation demand building through the quarter.

Why did the price of Lorazepam change in Q1 2026 in Germany?

The formulation demand built through the quarter, tracking the pharmaceutical-manufacturing activity closely.

Quarterly Lorazepam Price Trends

The global average climbed steadily across the window, from USD 225/KG in Q1 2025 to USD 246 by Q2 2026, a net gain of about 9.3%. Every quarter posted a gain here, reflecting the firming chlorobenzophenone feedstock costs and the steady formulation and hospital demand across every market we track, with the pace of the gains picking up somewhat in the most recent two quarters. That kind of steady, uninterrupted climb is worth noting, since it stands in contrast to how choppy some other commodities in this space have looked over the same period.

What was Lorazepam Price in 2025?

2025 was a steadily firming year for lorazepam. Starting near USD 225/KG in Q1, the global average finished 2025 at USD 236, a gain of about 4.9%. The pharmaceutical-formulation demand held consistent all year across every market we track, before the pace of gains stayed just as strong once 2026 got underway. The consistency of that pattern across all four regions makes this one of the more predictable, if tightly regulated, pharmaceutical markets we track. Buyers who track this market closely tend to view that steady annual pattern as the baseline against which any future quarter's move should be judged.

Lorazepam Prices in China in 2025

Chinese prices moved from about USD 185/KG in Q1 2025 to USD 191 by Q4, up roughly 3.2%. The domestic demand held steady all year, and China stayed the most affordable of the four markets throughout.

Lorazepam Prices in India in 2025

Indian prices climbed from USD 205/KG in Q1 to USD 213 by Q4, a 3.9% gain, tracking the steady formulation demand.

Lorazepam Prices in United States in 2025

US prices rose from USD 280/KG in Q1 to USD 292 by Q4, up 4.3%, the highest absolute price throughout the four markets on the steady hospital demand.

Lorazepam Prices in Germany in 2025

German prices moved from USD 260/KG in Q1 to USD 272 by Q4, a 4.6% gain, as the formulation demand kept building through the year.

How We Can Help

Expert Market Research: Your Source for Real-Time Lorazepam Price Intelligence

We keep a continuous eye on the lorazepam prices wherever it's produced or consumed at scale, tracing causation through the chlorobenzophenone feedstock economics, the pharmaceutical-formulation demand, and the specialized, controlled-substance-licensed production capacity utilization. Our analysts track the limited pool of qualified manufacturers closely, given how directly regulatory licensing constraints shape this market's supply picture. We also flag any material shift in the underlying feedstock or trade-logistics conditions as soon as it becomes apparent. Need pricing data, bespoke market analysis, or procurement advisory? Reach out to our team.